C24H33BCl2N2O4
Neat
495.26
Ixazomib Impurity 1; 1201903-02-7; 2, 5-Dichloro-N-[2-[[(1R)-3-methyl-1-[(1S, 2S, 6R, 8S)-2, 9, 9-trimethyl-3, 5-dioxa-4-boratricyclo[6.1.1.02, 6]decan-4-yl]butyl]amino]-2-oxoethyl]benzamide; 2, 5-dichloro-N-(2-(((R)-3-methyl-1-((3aS, 4S, 6S, 7aR)-3a, 5, 5-trimethylhexahydro-4, 6-methanobenzo[d][1, 3, 2]dioxaborol-2-yl)butyl)amino)-2-oxoethyl)benzamide; 2, 5-Dichloro-N-[2-[[(1R)-1-[(3aS, 4S, 6S, 7aR)-hexahydro-3a, 5, 5-trimethyl-4, 6-methano-1, 3, 2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxoethyl]-benzamide; Ixazomib Impurity N1; Y4Q5UL8FVU; SCHEMBL4420983; 2, 5-Dichloro-N-[2-[[(1R)-1-[(3aS, 4S, 6S, 7aR)-hexahydro-3a, 5, 5-trimethyl-4, 6-methano-1, 3, 2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxoethyl]benzamide; Benzamide, 2, 5-dichloro-N-[2-[[(1R)-1-[(3aS, 4S, 6S, 7aR)-hexahydro-3a, 5, 5-trimethyl-4, 6-methano-1, 3 and 2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxoethyl]-
2, 5-dichloro-N-[2-[[(1R)-3-methyl-1-[(1S, 2S, 6R, 8S)-2, 9, 9-trimethyl-3, 5-dioxa-4-boratricyclo[6.1.1.02 and 6]decan-4-yl]butyl]amino]-2-oxoethyl]benzamide
InChI=1S/C24H33BCl2N2O4/c1-13(2)8-20(25-32-19-10-14-9-18(23(14,3)4)24(19,5)33-25)29-21(30)12-28-22(31)16-11-15(26)6-7-17(16)27/h6-7,11,13-14,18-20H,8-10,12H2,1-5H3,(H,28,31)(H,29,30)/t14-,18-,19+,20-,24-/m0/s1